Cordis S.M.A.R.T.® Control® Nitinol Stent Transhepatic Biliary System - HSA Registration DE0003943
Access comprehensive regulatory information for Cordis S.M.A.R.T.® Control® Nitinol Stent Transhepatic Biliary System in the Singapore medical device market through Pure Global AI's free database. This CLASS C medical device is registered under HSA registration number DE0003943 and owned by Cordis Corporation. The device was registered on September 28, 2006.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Indicated for palliation of malignant neoplasms in the biliary tree.

